Underscoring the immense potential of chitosan in fighting a wide spectrum of viruses: A plausible molecule against SARS-CoV-2?
Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...
cidrap.umn1d
Data: Despite high risk of poor outcomes, only 1% of pregnant COVID patients given antiviral
PAHO is tracking a rise in dengue serogroup 3 activity, which could raise the risk of severe illness as countries approach the peak of the season.
Le Lézard11h
Cutting-edge Recommendations Provide Treatment Path for Millions of Long COVID Patients
Long COVID, a debilitating condition following SARS-CoV-2 infection, continues to disable tens of millions of people globally, yet no approved treatments ...
Protection from COVID reinfections plummeted from 80% to 5% with omicron
With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...
NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...
No, Moderna Did Not Create Its COVID Vaccine Two Years Before the Pandemic
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
pulmonologyadvisor4d
COVID Antiviral, mAb Treatments Reduce Mortality and Hospitalization Rates
Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.
The Lancet1d
Management and mechanisms of eosinophil action in asthma: mind the gap?
The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...